Literature DB >> 2481482

Thymosthenic agents, a novel approach in the treatment of schizophrenia.

Y G Gelders1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481482

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN： 0960-5371


× No keyword cloud information.
  11 in total

Review 1.  Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.

Authors:  J M Kane
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 2.  Serotonin, dopamine and their interactions in schizophrenia.

Authors:  R S Kahn; M Davidson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland.

Authors:  H J Möller; J Bäuml; F Ferrero; J Fuger; C Geretsegger; S Kasper; W Kissling; H Schubert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

Authors:  P Hertel; G G Nomikos; M Iurlo; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

5.  Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.

Authors:  Y Noda; K Yamada; H Furukawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

7.  Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

Authors:  G G Nomikos; M Iurlo; J L Andersson; K Kimura; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

8.  Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.

Authors:  Olivia Frånberg; Monica M Marcus; Vladimir Ivanov; Björn Schilström; Mohammed Shahid; Torgny H Svensson
Journal:  Psychopharmacology (Berl)       Date:  2009-02-07       Impact factor: 4.530

Review 9.  Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.

Authors:  S Grant; A Fitton
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

10.  Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

Authors:  Charlotte Wiker; Love Linnér; Marie-Louise Wadenberg; Torgny H Svensson
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.